Introduction: Liver cirrhosis disrupts the gut–liver axis through dysbiosis, intestinal barrier impairment, and bacterial translocation, which drive systemic inflammation. Objective: To analyze the correlation of fecal short-chain fatty acids (SCFA) and fecal calprotectin with high-sensitivity C-reactive protein (hsCRP) levels in patients with liver cirrhosis. Method: This analytic cross-sectional study enrolled 32 consecutive patients with cirrhosis at Prof. Dr. R. D. Kandou General Hospital, Manado. Fecal SCFA were measured by gas chromatography–mass spectrometry, fecal calprotectin by ELISA, and serum hsCRP by immunoturbidimetry. Data were analyzed using the Shapiro–Wilk test and Spearman's correlation. Result and Discussion: The mean age was 57.16 ± 11.27 years and 81.3% of subjects were male. The median hsCRP was 2.60 mg/L (IQR 9.55) and the median fecal calprotectin was 232.55 µg/g (IQR 538.40), with elevated fecal calprotectin in 65.6% of subjects. Fecal calprotectin showed a significant moderate positive correlation with hsCRP (r = 0.520; p = 0.002), whereas total SCFA did not correlate with hsCRP (r = 0.013; p = 0.944) or fecal calprotectin (r = 0.106; p = 0.562). Conclusions: Intestinal mucosal inflammation, reflected by fecal calprotectin, is associated with systemic inflammation in liver cirrhosis, whereas total fecal SCFA alone is insufficient as an inflammatory biomarker
Copyrights © 2026